Intelligent Bio Solutions Total Assets 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions total assets from 2020 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions total assets from 2020 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$151.4B
CVS Health (CVS)	$89.8B
Elevance Health (ELV)	$69.8B
Cencora (COR)	$58.9B
DiDi Global (DIDIY)	$28.4B
Labcorp Holdings (LH)	$23.1B
Natera (NTRA)	$22B
BioMerieux (BMXMF)	$17.6B
EUROFINS SCIENT (ERFSF)	$15.7B
ICON (ICLR)	$14.6B
Medpace Holdings (MEDP)	$13.1B
Solventum (SOLV)	$12.6B
CochLear (CHEOY)	$12.5B
Viatris (VTRS)	$12.4B
Revvity (RVTY)	$10.6B
Caris Life Sciences,�Inc (CAI)	$9.9B
Sonic Healthcare (SKHHY)	$9.2B
Avantor (AVTR)	$8.8B
Charles River Laboratories (CRL)	$7.9B
HealthEquity (HQY)	$7.7B
Bausch + Lomb (BLCO)	$5.1B
Sotera Health (SHC)	$4.6B
BrightSpring Health Services (BTSG)	$4.2B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.5B
Surgery Partners (SGRY)	$3.1B
Alignment Healthcare (ALHC)	$3B
Concentras Parent (CON)	$3B
Organon (OGN)	$2.4B
Premier (PINC)	$2.1B